CD4 and malaria: The strategy of using the domains that concentrate the most relevant epitopes was the basis of the development of the development of the vaccines against human malaria (central and C-terminal domain) (73), HIV (CD4 and co-receptor binding domains) (74), and influenza [extracellular domain of matrix protein 2 (M2e)] (75).